Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Asia Pacific Drug Development Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Asia Pacific Drug Development Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Asia Pacific Drug Development Market: Mode Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Asia Pacific Drug Development Market: Mode Movement Analysis, 2023 & 2030 (USD Million)
4.3. In House
4.3.1. In House Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Outsourced
4.4.1. Outsourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Asia Pacific Drug Development Market: Process Step Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Asia Pacific Drug Development Market: Process Step Movement Analysis, 2023 & 2030 (USD Million)
5.3. Process Research Development
5.3.1. Process Research Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Formulation
5.4.1. Formulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Analytical & Stability Studies
5.5.1. Analytical & Stability Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. DMPK
5.6.1. DMPK Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Safety Assessment (Toxicology)
5.7.1. Safety Assessment (Toxicology) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Regulatory Compliance
5.8.1. Regulatory Compliance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Packaging
5.9.1. Packaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Asia Pacific Drug Development Market: Therapeutic Area Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Asia Pacific Drug Development Market: Therapeutic Area Movement Analysis, 2023 & 2030 (USD Million)
6.3. Oncology
6.3.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Inflammation & Immunology
6.4.1. Inflammation & Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Cardiology
6.5.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Neuroscience
6.6.1. Neuroscience Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Others
6.7.1. Others Therapeutic Area Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Asia Pacific Drug Development Market: Regional Estimates & Trend Analysis
7.1. Asia Pacific Drug Development Market Share, By Country, 2023 & 2030 (USD Million)
7.2. China
7.2.1. China Drug Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Japan
7.3.1. Japan Drug Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. India
7.4.1. India Drug Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Australia
7.5.1. Australia Drug Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. South Korea
7.6.1. South Korea Drug Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Thailand
7.7.1. Thailand Drug Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Samsung Biologics
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/Strategic Initiatives
8.4.2. WuXi Biologics
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/Strategic Initiatives
8.4.3. CELLTRION INC
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/Strategic Initiatives
8.4.4. PT Kalbe Farma Tbk.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/Strategic Initiatives
8.4.5. Eurofins Advinus
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/Strategic Initiatives
8.4.6. Laboratory Corporation of America
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/Strategic Initiatives
8.4.7. Celerion
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/Strategic Initiatives
8.4.8. Parexel International (MA) Corporation
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/Strategic Initiatives